Verve Therapeutics' gene editing therapy may cure heart attacks once and for all
Bloomberg - 06-May-2022Trials underway to test the safety, but affordability and acceptance of gene therapy are major concerns
Join the club for FREE to access the whole archive and other member benefits.
Health reporter at Bloomberg
Angelica Peebles is a health reporter at Bloomberg News covering the business of developing and selling prescription drugs, from biotech to pharmacies and other stories in between. Previously, she worked as a health reporter at CNBC.
Angelical completed BS in News-Editorial Journalism from University of Illinois.
Visit website: https://www.bloomberg.com/authors/AUdOq5Fz5GM/angelica-lavito
See also: Bloomberg - Media company covering business and financial data, news and insight
Details last updated 10-May-2022
Trials underway to test the safety, but affordability and acceptance of gene therapy are major concerns